GTAM
IONS icon

Global Trust Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Global Trust Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.4K Hold
218
– – 0.01% 335
2025
Q4 		$17.2K Hold
218
– – 0.01% 313
2025
Q3 		$14.3K Hold
218
– – 0.01% 373
2025
Q2 		$8.61K Sell
218
-181
-45% -$5.92K ﹤0.01% 386
2025
Q1 		$12K Hold
399
– – 0.01% 349
2024
Q4 		$13.9K Sell
399
-75
-16% -$2.8K 0.01% 388
2024
Q3 		$19K Hold
474
– – 0.01% 348
2024
Q2 		$22.6K Hold
474
– – 0.01% 309
2024
Q1 		$20.5K Hold
474
– – 0.01% 312
2023
Q4 		$24K Hold
474
– – 0.01% 288
2023
Q3 		$21.5K Buy
474
+75
+19% +$3.09K 0.01% 290
2023
Q2 		$16.4K Hold
399
– – 0.01% 306
2023
Q1 		$14.3K Hold
399
– – 0.01% 299
2022
Q4 		$15.1K Hold
399
– – 0.01% 284
2022
Q3 		$18K Hold
399
– – 0.01% 288
2022
Q2 		$15K Hold
399
– – 0.01% 295
2022
Q1 		$15K Hold
399
– – 0.01% 351
2021
Q4 		$12K Hold
399
– – ﹤0.01% 335
2021
Q3 		$13K Hold
399
– – 0.01% 306
2021
Q2 		$16K Hold
399
– – 0.01% 297
2021
Q1 		$18K Buy
+399
New +$22.3K 0.01% 263

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Global Trust Asset Management's IONS Position: Q1 2026 in Review

Global Trust Asset Management held its Ionis Pharmaceuticals (IONS) position steady in Q1 2026 at 218 shares worth $16.4K. The position accounts for 0.01% of the portfolio, ranked #335.

Global Trust Asset Management first reported a position in IONS in Q1 2021 and has held it in 21 quarters since. The position peaked at $24K in Q4 2023. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Global Trust Asset Management held 218 shares of Ionis Pharmaceuticals worth $16.4K as of Q1 2026.
  • Global Trust Asset Management left its Ionis Pharmaceuticals share count unchanged in Q1 2026.
  • Ionis Pharmaceuticals made up 0.01% of Global Trust Asset Management's portfolio in Q1 2026, its #335 holding.
  • Global Trust Asset Management first reported a position in Ionis Pharmaceuticals in Q1 2021 and has held it in 21 quarters since.
  • Global Trust Asset Management's Ionis Pharmaceuticals position peaked at $24K in Q4 2023.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Global Trust Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.